OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
27
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Transcriptomics
(5)
Organisms
Mus musculus
(5)
Repository
biostudies-arrayexpress
(5)
Publication Date
2009
(5)
Study type
Transcription profiling by array
(5)
Release Date
2009
(5)
2023
(5)
2025
(3)
2024
(3)
2022
(3)
2018
(2)
2016
(2)
2019
(1)
2015
(1)
2014
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Not available
S-EPMC4879714
|
biostudies-literature
Cite
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Not available
S-EPMC9991855
|
biostudies-literature
Cite
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study.
Not available
S-EPMC10589773
|
biostudies-literature
Cite
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2
EV
Study.
Not available
S-EPMC11557677
|
biostudies-literature
Cite
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma.
Not available
S-EPMC12824663
|
biostudies-literature
Cite
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.
Not available
S-EPMC12824668
|
biostudies-literature
Cite
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.
Not available
S-EPMC6073588
|
biostudies-literature
Cite
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Not available
S-EPMC3515768
|
biostudies-literature
Cite
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Not available
S-EPMC4026579
|
biostudies-literature
Cite
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Not available
S-EPMC8952186
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets